The global kidney function tests market is
expected to reach USD 1.9 billion by 2025, according to a new study by Grand
View Research, Inc. The growing prevalence of Chronic Kidney Diseases (CKD) and
renal failure is presumed to be responsible for the high urgency to use kidney
function tests, which is anticipated tobroaden the scope for growth throughout
the forecast period. In addition, expanding base of diabetic population, which
is highly susceptible to the aforementioned diseases, is predicted to impel the
demand further over the coming years. Consequently, resultant high sample
volume will require high capability kidney function testing devices, which is
believed to present the market with significant growth potential opportunities.
In addition, growing awareness
with respect to diagnostic benefits associated with kidney function tests is
also anticipated to be one of the high impact rendering drivers for this
market. Emergence of technologically advanced products, such as automated
analyzers, has led to refinement of current real-time point-of-care testing
capabilities and, therefore, creates lucrative growth opportunities for the
market. Furthermore, presence of public as well private healthcare
organizations consistently striving to support diagnosis and management of CKD
through a range of programs and initiatives is expected to create potential
demand.
Browse full research report on Global Kidney Function Tests Market: http://www.grandviewresearch.com/industry-analysis/kidney-function-tests-market
Further key findings from
the study suggest:
- Imaging tests are expected to exhibit lucrative CAGR owing to increasing adoption in wide array of clinical applications. The high penetration can be attributed to efficient renal function risk assessment due to abnormal results generated through other tests
- Diagnostic laboratories are anticipated to exhibit lucrative CAGR during the forecast period owing to increasing preference for point-of-care testing by clinicians
- In 2016, North America held a dominant share of the global kidney function tests market, as a consequence of increasing local presence of prominent companies undertaking competitive sustainability strategies
- Asia Pacific is anticipated to grow at an exponential CAGR owing to unmet needs of patients, continuous infrastructural & technological upgradation, and increasing healthcare expenditure
- Some key participants such as Abbott Laboratories; Merck Millipore; Alere, Inc.; and Quest Diagnostics are implementing various competitive strategies, such as new product development & frequent product approvals, to maintain their position in the market
- For instance, in March 2015, metropolis announced the launch of a kidney function test, a PLA2R antibody test, that detects and evaluates intensity of membranous nephropathy
Grand View Research has segmented the kidney function tests
market on the basis of product, end
use, and region:
Kidney Function Tests Product Outlook (Revenue, USD
Million, 2014 - 2025)
- Dilution & Concentration Tests
- Clearance Tests
- Urine Tests
- Imaging Tests
Kidney Function Tests End-Use Outlook (Revenue, USD
Million, 2014 - 2025)
- Hospitals
- Diagnostic Laboratories
- Academic Research Laboratories
- Others
Kidney Function Tests Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment